The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Abstract
Preface. List of examples. 1. Introduction. 1.1 What are Bayesian methods? 1.2 What do we mean by 'health--care evaluation'? 1.3 A Bayesian approach to evaluation. 1.4 The aim of this book and the intended audience. 1.5 Structure of the book. 2. Basic Concepts from Traditional Statistical Analysis. 2.1 Probability. 2.1.1 What is probability? 2.1.2 Odds and log--odds. 2.1.3 Bayes theorem for simple events. 2.2 Random variables, parameters and likelihood. 2.2.1 Random variables and their distributions. 2.2.2 Expectation, variance, covariance and correlation. 2.2.3 Parametric distributions and conditional independence. 2.2.4 Likelihoods. 2.3 The normal distribution. 2.4 Normal likelihoods. 2.4.1 Normal approximations for binary data. 2.4.2 Normal likelihoods for survival data. 2.4.3 Normal likelihoods for count responses. 2.4.4 Normal likelihoods for continuous responses. 2.5 Classical inference. 2.6 A catalogue of useful distributionsaeo. 2.6.1 Binomial and Bernoulli. 2.6.2 Poisson. 2.6.3 Beta. 2.6.4 Uniform. 2.6.5 Gamma. 2.6.6 Root--inverse--gamma. 2.6.7 Half--normal. 2.6.8 Log--normal. 2.6.9 Student's t. 2.6.10 Bivariate normal. 2.7 Key points. Exercises. 3. An Overview of the Bayesian Approach. 3.1 Subjectivity and context. 3.2 Bayes theorem for two hypotheses. 3.3 Comparing simple hypotheses: likelihood ratios and Bayes factors. 3.4 Exchangeability and parametric modellingaeo. 3.5 Bayes theorem for general quantities. 3.6 Bayesian analysis with binary data. 3.6.1 Binary data with a discrete prior distribution. 3.6.2 Conjugate analysis for binary data. 3.7 Bayesian analysis with normal distributions. 3.8 Point estimation, interval estimation and interval hypotheses. 3.9 The prior distribution. 3.10 How to use Bayes theorem to interpret trial results. 3.11 The 'credibility' of significant trial resultsaeo. 3.12 Sequential use of Bayes theoremaeo. 3.13 Predictions. 3.13.1 Predictions in the Bayesian framework. 3.13.2 Predictions for binary dataaeo. 3.13.3 Predictions for normal data. 3.14 Decision--making. 3.15 Design. 3.16 Use of historical data. 3.17 Multiplicity, exchangeability and hierarchical models. 3.18 Dealing with nuisance parametersaeo. 3.18.1 Alternative methods for eliminating nuisance parametersaeo. 3.18.2 Profile likelihood in a hierarchical modelaeo. 3.19 Computational issues. 3.19.1 Monte Carlo methods. 3.19.2 Markov chain Monte Carlo methods. 3.19.3 WinBUGS. 3.20 Schools of Bayesians. 3.21 A Bayesian checklist. 3.22 Further reading. 3.23 Key points. Exercises. 4. Comparison of Alternative Approaches to Inference. 4.1 A structure for alternative approaches. 4.2 Conventional statistical methods used in health--care evaluation. 4.3 The likelihood principle, sequential analysis and types of error. 4.3.1 The likelihood principle. 4.3.2 Sequential analysis. 4.3.3 Type I and Type II error. 4.4 P--values and Bayes factorsaeo. 4.4.1 Criticism of P--values. 4.4.2 Bayes factors as an alternative to P--values: simple hypotheses. 4.4.3 Bayes factors as an alternative to P--values: composite hypotheses. 4.4.4 Bayes factors in preference studies. 4.4.5 Lindley's paradox. 4.5 Key points. Exercises. 5. Prior Distributions. 5.1 Introduction. 5.2 Elicitation of opinion: a brief review. 5.2.1 Background to elicitation. 5.2.2 Elicitation techniques. 5.2.3 Elicitation from multiple experts. 5.3 Critique of prior elicitation. 5.4 Summary of external evidenceaeo. 5.5 Default priors. 5.5.1 'Non--informative' or 'reference' priors: 5.5.2 'Sceptical' priors. 5.5.3 'Enthusiastic' priors. 5.5.4 Priors with a point mass at the null hypothesis ('lump--and--smear' priors)aeo. 5.6 Sensitivity analysis and 'robust' priors. 5.7 Hierarchical priors. 5.7.1 The judgement of exchangeability. 5.7.2 The form for the random--effects distribution. 5.7.3 The prior for the standard deviation of the random effectsaeo. 5.8 Empirical criticism of priors. 5.9 Key points. Exercises. 6. Randomised Controlled Trials. 6.1 Introduction. 6.2 Use of a loss function: is a clinical trial for inference or decision? 6.3 Specification of null hypotheses. 6.4 Ethics and randomisation: a brief review. 6.4.1 Is randomisation necessary? 6.4.2 When is it ethical to randomise? 6.5 Sample size of non--sequential trials. 6.5.1 Alternative approaches to sample--size assessment. 6.5.2 'Classical power': hybrid classical--Bayesian methods assuming normality. 6.5.3 'Bayesian power'. 6.5.4 Adjusting formulae for different hypotheses. 6.5.5 Predictive distribution of power and necessary sample size. 6.6 Monitoring of sequential trials. 6.6.1 Introduction. 6.6.2 Monitoring using the posterior distribution. 6.6.3 Monitoring using predictions: 'interim power'. 6.6.4 Monitoring using a formal loss function. 6.6.5 Frequentist properties of sequential Bayesian methods. 6.6.6 Bayesian methods and data monitoring committees. 6.7 The role of 'scepticism' in confirmatory studies. 6.8 Multiplicity in randomised trials. 6.8.1 Subset analysis. 6.8.2 Multi--centre analysis. 6.8
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Gelman, A., Carlin, J. B., Stern, H. S., & Rubin, D. B. (2003) · doi:10.1201/9780429258480 · Cited by 27,276
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Bayesian Inference in Statistical Analysis.
Kadane, J. B., Box, G. E. P., & Tiao, G. C. (1975) · Journal of the American Statistical Association · doi:10.2307/2285412 · Cited by 3,824
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
Concato, J., Shah, N., & Horwitz, R. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422507 · Cited by 3,563
Framework for design and evaluation of complex interventions to improve health
Campbell, M. (2000) · BMJ · doi:10.1136/bmj.321.7262.694 · Cited by 3,474 · cited 1×
“public health interventions (Campbell et al., 2000): in phase I an intervention is developed possibly through a theoretical model; in phase II explanatory trials in tightly controlled situations seek to demonstrate the potential efficacy of the intervention; in phase III pragmatic trials evaluate its costs and effecti…”
Optimal Statistical Decisions.
Siegmund, D., & DeGroot, M. H. (1972) · Journal of the American Statistical Association · doi:10.2307/2284675 · Cited by 3,386
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378
AN ESSAY TOWARDS SOLVING A PROBLEM IN THE DOCTRINE OF CHANCES
BAYES (1958) · Biometrika · doi:10.1093/biomet/45.3-4.296 · Cited by 2,911
Moher, D., Schulz, K. F., & Altman, D. G. (2001) · BMC Medical Research Methodology · doi:10.1186/1471-2288-1-2 · Cited by 2,755
Casella, G., & George, E. I. (1992) · The American Statistician · doi:10.1080/00031305.1992.10475878 · Cited by 2,364
A comparison of observational studies and randomized, controlled trials.
Benson, K., & Hartz, A. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006223422506 · Cited by 2,347
Equipoise and the Ethics of Clinical Research
Freedman, B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198707163170304 · Cited by 2,339
Bayes and Empirical Bayes Methods for Data Analysis
(2001) · Technometrics · doi:10.1198/tech.2001.s608 · Cited by 2,098
Bayesian Experimental Design: A Review
Chaloner, K., & Verdinelli, I. (1995) · Statistical Science · doi:10.1214/ss/1177009939 · Cited by 1,839
(2000) · Queen Mary Research Online (Queen Mary University of London) · Cited by 1,795
Bayesian statistical inference for psychological research.
Edwards, W., Lindman, H., & Savage, L. J. (1963) · Psychological Review · doi:10.1037/h0044139 · Cited by 1,734
Why we need observational studies to evaluate the effectiveness of health care
Black, N. (1996) · BMJ · doi:10.1136/bmj.312.7040.1215 · Cited by 1,598
Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer
O'Quigley, J., Pepe, M., & Fisher, L. (1990) · Biometrics · doi:10.2307/2531628 · Cited by 1,577
The Selection of Prior Distributions by Formal Rules
Kass, R. E., & Wasserman, L. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10477003 · Cited by 1,308
A Reference Bayesian Test for Nested Hypotheses and its Relationship to the Schwarz Criterion
Kass, R. E., & Wasserman, L. (1995) · Journal of the American Statistical Association · doi:10.1080/01621459.1995.10476592 · Cited by 1,253
Scientific reasoning: the Bayesian approach
(1990) · Choice Reviews Online · doi:10.5860/choice.27-2696 · Cited by 1,245
Elicitation of Personal Probabilities and Expectations
Savage, L. J. (1971) · Journal of the American Statistical Association · doi:10.1080/01621459.1971.10482346 · Cited by 1,226
Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy
Goodman, S. N. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-12-199906150-00008 · Cited by 1,185
Statistical Methods in Epidemiology
(2012) · SpringerReference · doi:10.1007/springerreference_205629 · Cited by 1,124
Geddes, J., Freemantle, N., Harrison, P., & Bebbington, P. (2000) · BMJ · doi:10.1136/bmj.321.7273.1371 · Cited by 1,062
Fitzpatrick, Shortall, Sculpher, Murray, Morris, Lodge, Dawson, Carr, Britton, & Briggs (1998) · Health Technology Assessment · doi:10.3310/hta2200 · Cited by 969
Costs, effects and C/E‐ratios alongside a clinical trial
Van Hout, B. A., Al, M. J., Gordon, G. S., & Rutten, F. F. H. (1994) · Health Economics · doi:10.1002/hec.4730030505 · Cited by 964
An Introduction to Markov Modelling for Economic Evaluation
Briggs, A., & Sculpher, M. (1998) · PharmacoEconomics · doi:10.2165/00019053-199813040-00003 · Cited by 960
Song, F., Altman, D. G., Glenny, A.-M., & Deeks, J. J. (2003) · BMJ · doi:10.1136/bmj.326.7387.472 · Cited by 943
Neyman, J. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_12 · Cited by 932
Comparison of Evidence of Treatment Effects in Randomized and Nonrandomized Studies
Ioannidis, J. P. A. (2001) · JAMA · doi:10.1001/jama.286.7.821 · Cited by 919
Claxton, K. (1999) · Journal of Health Economics · doi:10.1016/s0167-6296(98)00039-3 · Cited by 889
Markov chain Monte Carlo method and its application
Brooks, S. (1998) · Journal of the Royal Statistical Society: Series D (The Statistician) · doi:10.1111/1467-9884.00117 · Cited by 843
Meta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Handling Uncertainty in Cost-Effectiveness Models
Briggs, A. H. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00006 · Cited by 807
Kunz, R., & Oxman, A. D. (1998) · BMJ · doi:10.1136/bmj.317.7167.1185 · Cited by 770
Repeated Significance Tests on Accumulating Data
Armitage, P., McPherson, C. K., & Rowe, B. C. (1969) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2343787 · Cited by 761
Power prior distributions for regression models
Chen, M.-H., & Ibrahim, J. G. (2000) · Statistical Science · doi:10.1214/ss/1009212673 · Cited by 732
A Bayes Rule for the Symmetric Multiple Comparisons Problem
Waller, R. A., & Duncan, D. B. (1969) · Journal of the American Statistical Association · doi:10.1080/01621459.1969.10501073 · Cited by 723
Bayesian methods in meta-analysis and evidence synthesis
Sutton, A. J., & Abrams, K. R. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000404 · Cited by 710
Self-citationThe Design and Analysis of Sequential Clinical Trials.
Harrington, D., & Whitehead, J. (1985) · Journal of the American Statistical Association · doi:10.2307/2288093 · Cited by 634
Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction: A Meta-analysis
Morrison, L. J., Verbeek, P. R., McDonald, A. C., Sawadsky, B. V., & Cook, D. J. (2000) · JAMA · doi:10.1001/jama.283.20.2686 · Cited by 612
The effect of elective total hip replacement on health-related quality of life.
Laupacis, A., Bourne, R., Rorabeck, C., Feeny, D., Wong, C., Tugwell, P., Leslie, K., & Bullas, R. (1993) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199311000-00006 · Cited by 609
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568
BORROWING STRENGTH FROM EXTERNAL TRIALS IN A META-ANALYSIS
HIGGINS, J. P. T., & WHITEHEAD, A. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19961230)15:24<2733::aid-sim562>3.0.co;2-0 · Cited by 557
Woods, K. L., Fletcher, S., Roffe, C., & Haider, Y. (1992) · The Lancet · doi:10.1016/0140-6736(92)91828-v · Cited by 537
Randomized Clinical Trials: Perspectives on Some Recent Ideas
Byar, D. P., Simon, R. M., Friedewald, W. T., Schlesselman, J. J., DeMets, D. L., Ellenberg, J. H., Gail, M. H., & Ware, J. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197607082950204 · Cited by 537
The combination of randomized and historical controls in clinical trials
Pocock, S. J. (1976) · Journal of Chronic Diseases · doi:10.1016/0021-9681(76)90044-8 · Cited by 514
Bayesian analysis of space—time variation in disease risk
Bernardinelli, L., Clayton, D., Pascutto, C., Montomoli, C., Ghislandi, M., & Songini, M. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142112 · Cited by 507
Principles of multilevel modelling
Greenland, S. (2000) · International Journal of Epidemiology · doi:10.1093/ije/29.1.158 · Cited by 481
Some Thoughts on Clinical Trials, Especially Problems of Multiplicity
Tukey, J. W. (1977) · Science · doi:10.1126/science.333584 · Cited by 479
Interpreting Parameters in the Logistic Regression Model with Random Effects
Larsen, K., Petersen, J. H., Budtz‐Jørgensen, E., & Endahl, L. (2000) · Biometrics · doi:10.1111/j.0006-341x.2000.00909.x · Cited by 473
Some practical improvements in the continual reassessment method for phase I studies
Goodman, S. N., Zahurak, M. L., & Piantadosi, S. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141102 · Cited by 472
Statistical Methods for Profiling Providers of Medical Care: Issues and Applications
Normand, S.-L. T., Glickman, M. E., & Gatsonis, C. A. (1997) · Journal of the American Statistical Association · doi:10.1080/01621459.1997.10474036 · Cited by 470
Play the Winner Rule and the Controlled Clinical Trial
Zelen, M. (1969) · Journal of the American Statistical Association · doi:10.1080/01621459.1969.10500959 · Cited by 451
Statistical analysis and the illusion of objectivity
(1988) · Infectious Diseases Newsletter · doi:10.1016/0278-2316(88)90057-6 · Cited by 408
An economic approach to clinical trial design and research priority-setting
Claxton, K., & Posnett, J. (1996) · Health Economics · doi:10.1002/(sici)1099-1050(199611)5:6<513::aid-hec237>3.0.co;2-9 · Cited by 395
Handling uncertainty when performing economic evaluation of healthcare interventions.
Briggs, & Gray (1999) · Health Technology Assessment · doi:10.3310/hta3020 · Cited by 387
Reliability of Subjective Probability Forecasts of Precipitation and Temperature
Murphy, A. H., & Winkler, R. L. (1977) · Applied Statistics · doi:10.2307/2346866 · Cited by 386
Sebranek, W., ., M., & Mason, S. T. (2011) · Cited by 371
Bayesian methods in health technology assessment: a review.
Spiegelhalter, Myles, Jones, & Abrams (2000) · Health Technology Assessment · doi:10.3310/hta4380 · Cited by 358
Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care
Lau, J., Schmid, C. H., & Chalmers, T. C. (1995) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(94)00106-z · Cited by 356
Anscombe, F. J. (1963) · Journal of the American Statistical Association · doi:10.1080/01621459.1963.10500851 · Cited by 339
Statistics: A Bayesian Perspective
Berry, D. A. (1995) · Medical Entomology and Zoology · Cited by 332
Kadane, J., & Wolfson, L. J. (1998) · Journal of the Royal Statistical Society: Series D (The Statistician) · doi:10.1111/1467-9884.00113 · Cited by 331
Teo, K. K., Yusuf, S., Collins, R., Held, P. H., & Peto, R. (1991) · BMJ · doi:10.1136/bmj.303.6816.1499 · Cited by 331
A bivariate approach to meta-analysis
Van Houwelingen, H. C., Zwinderman, K. H., & Stijnen, T. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122405 · Cited by 327
Sensitivity Analysis and the Expected Value of Perfect Information
Felli, J. C., & Hazen, G. B. (1998) · Medical Decision Making · doi:10.1177/0272989x9801800117 · Cited by 327
Choosing between randomised and non-randomised studies: a systematic review.
Britton, McKee, Black, McPherson, Sanderson, & Bain (1998) · Health Technology Assessment · doi:10.3310/hta2130 · Cited by 308
Monitoring clinical trials: Conditional or predictive power?
Spiegelhalter, D. J., Freedman, L. S., & Blackburn, P. R. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90003-6 · Cited by 307
Self-citationEmpirical bayes meta-analysis.
Raudenbush, S. W., & Bryk, A. S. (1985) · Journal of Educational Statistics · doi:10.3102/10769986010002075 · Cited by 299 · cited 1×
“Empirical Bayes approaches for meta-analysis have received most attention in the literatureuntil recently, largely because of computational difficulties in theuse of fully Bayesian modelling (Raudenbush and Bryk, 1985; Stijnen and van Houwelingen, 1990).”
Theory of Probability (3rd Edition)
Litton, C. D. (1984) · Journal of the Operational Research Society · doi:10.1057/jors.1984.141 · Cited by 282
Thall, P. F., & Russell, K. E. (1998) · Biometrics · doi:10.2307/2534012 · Cited by 278
Warn, D. E., Thompson, S. G., & Spiegelhalter, D. J. (2002) · Statistics in Medicine · doi:10.1002/sim.1189 · Cited by 277 · cited 1×
“It is also possible to make inferences on a variety of scales, such as risk difference, risk ratio and odds ratio (Carlin, 2000; Warn et al., 2002).”
Self-citationSpiegelhalter, D. J., & Freedman, L. S. (1986) · Statistics in Medicine · doi:10.1002/sim.4780050103 · Cited by 276
Self-citationFunzione caratteristica di un fenomeno aleatorio
de Finetti, B. (1929) · Dialnet (Universidad de la Rioja) · Cited by 275
Issues in data monitoring and interim analysis of trials
Grant, A., Altman, D., Babiker, A., Campbell, M., Clemens, F., Darbyshire, J., Elbourne, D., McLeer, S., Parmar, M., Pocock, S., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9070 · Cited by 269
Self-citationMETA-ANALYSIS IN THE DESIGN AND MONITORING OF CLINICAL TRIALS
DERSIMONIAN, R. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960630)15:12<1237::aid-sim301>3.0.co;2-n · Cited by 257
The Effect of Sample Size on the Meaning of Significance Tests
Royall, R. M. (1986) · The American Statistician · doi:10.1080/00031305.1986.10475424 · Cited by 257
When to stop a clinical trial.
Pocock, S. J. (1992) · BMJ · doi:10.1136/bmj.305.6847.235 · Cited by 255 · cited 1×
“6) and is often represented as a balance between individual and collective ethics (Pocock, 1992; Palmer and Rosenberger, 1999): individual ethics would suggest that it is inappropriate to randomise a patient to a treatment near the end of a trial in which one could be reasonably confident as to another treatment’s sup…”
Markov chain Monte Carlo methods in biostatistics
Gelman, A., & Rubin, D. B. (1996) · Statistical Methods in Medical Research · doi:10.1177/096228029600500402 · Cited by 255
Peto, R., & Baigent, C. (1998) · BMJ · doi:10.1136/bmj.317.7167.1170 · Cited by 243
Clinical trials and rare diseases: A way out of a conundrum
Lilford, R. J., Thornton, J. G., & Braunholtz, D. (1995) · BMJ · doi:10.1136/bmj.311.7020.1621 · Cited by 237
Investigating underlying risk as a source of heterogeneity in meta-analysis
Thompson, S. G., Smith, T. C., & Sharp, S. J. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19971215)16:23<2741::aid-sim703>3.0.co;2-0 · Cited by 226
Statistical Issues in Drug Development
Ziegel, E. R., & Senn, S. (1999) · Technometrics · doi:10.2307/1271380 · Cited by 224
Zucker, D. R., Schmid, C. H., McIntosh, M. W., D'Agostino, R. B., Selker, H. P., & Lau, J. (1997) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(96)00429-5 · Cited by 218
Improving the Statistical Approach to Health Care Provider Profiling
Christiansen, C. L., & Morris, C. N. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00065 · Cited by 216
Sculpher, M., Fenwick, E., & Claxton, K. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017050-00005 · Cited by 212
Meta-Analysis in Medicine and Health Policy
(2000) · CRC Press eBooks · doi:10.1201/9780203909935 · Cited by 211
Reference Bayesian Methods for Generalized Linear Mixed Models
Natarajan, R., & Kass, R. E. (2000) · Journal of the American Statistical Association · doi:10.1080/01621459.2000.10473916 · Cited by 209
Sequential Trials, Sequential Analysis and the Likelihood Principle
Cornfield, J. (1966) · The American Statistician · doi:10.1080/00031305.1966.10479786 · Cited by 205
Bennett, C. C., Johnson, A., Field, D. J., & Elbourne, D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04310-5 · Cited by 203
Assessing Normality in Random Effects Models
Lange, N., & Ryan, L. (1989) · The Annals of Statistics · doi:10.1214/aos/1176347130 · Cited by 203
Equipoise and the ethics of randomization.
Lilford, R. J., & Jackson, J. (1995) · Europe PMC (PubMed Central) · Cited by 201
An aid to data monitoring in long-term clinical trials
Halperin, M., Gordon Lan, K. K., Ware, J. H., Johnson, N. J., & DeMets, D. L. (1982) · Controlled Clinical Trials · doi:10.1016/0197-2456(82)90022-8 · Cited by 195
Adaptive assignment versus balanced randomization in clinical trials: A decision analysis
Berry, D. A., & Eick, S. G. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140302 · Cited by 195
For Debate: The statistical basis of public policy: a paradigm shift is overdue
Lilford, R. J., & Braunholtz, D. (1996) · BMJ · doi:10.1136/bmj.313.7057.603 · Cited by 188
The evolving case-control study
Cole, P. (1979) · Journal of Chronic Diseases · doi:10.1016/0021-9681(79)90006-7 · Cited by 173
Bayesian Methods in Practice: Experiences in the Pharmaceutical Industry
Racine, A., Grieve, A. P., Fluhler, H., & Smith, A. F. M. (1986) · Applied Statistics · doi:10.2307/2347264 · Cited by 170
TSIATIS, A. A. (1981) · Biometrika · doi:10.1093/biomet/68.1.311 · Cited by 169
Hierarchical Poisson Regression Modeling
Christiansen, C. L., & Morris, C. N. (1997) · Journal of the American Statistical Association · doi:10.1080/01621459.1997.10474013 · Cited by 165
Meta‐analysis for 2 × 2 tables: A bayesian approach
Carlin, J. B. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110202 · Cited by 164
Richardson, S., & Gilks, W. R. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116875 · Cited by 163
A case for bayesianism in clinical trials
Berry, D. A. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121504 · Cited by 161
Practical problems in interim analyses, with particular regard to estimation
Pocock, S. J., & Hughes, M. D. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90059-7 · Cited by 160
Ayanian, J. Z., Landrum, M. B., Normand, S.-L. T., Guadagnoli, E., & McNeil, B. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382608 · Cited by 159
Leonard, T. J. (2001) · Cited by 159
Ethical Issues in the Design and Conduct of Randomised Controlled Trials
Lilford, R. J., Edwards, S., Braunholtz, D., Jackson, J. E., Thornton, J., & Hewison, J. (2001) · SAGE Publications Ltd eBooks · doi:10.4135/9781848608344.n1 · Cited by 156
Placing Trials in Context Using Bayesian Analysis
Brophy, J. M. (1995) · JAMA · doi:10.1001/jama.1995.03520350053028 · Cited by 154
Statistics notes: Bayesians and frequentists
Bland, J. M., & Altman, D. G. (1998) · BMJ · doi:10.1136/bmj.317.7166.1151 · Cited by 152
Statistics and Ethics in Surgery and Anesthesia
Gilbert, J., McPeek, B., & Mosteller, F. C. (1977) · Science · doi:10.1126/science.333585 · Cited by 152
MeWAnalysis by the Confidence Profile Method: The Statistical Synthesis of Evidence
Lenth, R. V., Eddy, D. M., Hasselblad, V., & Shachter, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10485067 · Cited by 148
BAYESIAN DECISION PROCEDURES FOR DOSE DETERMINING EXPERIMENTS
Whitehead, J., & Brunier, H. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140904 · Cited by 144
The Use of Historical Control Information in Testing for a Trend in Proportions
Tarone, R. E. (1982) · Biometrics · doi:10.2307/2530304 · Cited by 143
BAYESIAN AND MIXED BAYESIAN/LIKELIHOOD CRITERIA FOR SAMPLE SIZE DETERMINATION
Joseph, L., du Berger, R., & Bélisle, P. (1997) · Statistics in Medicine · Cited by 143
Evidence-based medicine as Bayesian decision-making
Ashby, D., & Smith, A. F. M. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001215)19:23<3291::aid-sim627>3.0.co;2-t · Cited by 143
Samsa, G. P., Reutter, R. A., Parmigiani, G., Ancukiewicz, M., Abrahamse, P., Lipscomb, J., & Matchar, D. B. (1999) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00151-6 · Cited by 140
Design Considerations for AIDS Trials
Byar, D. P., Schoenfeld, D., Green, S. B., Amato, D. A., Davis, R., Gruttola, V. D., Finkelstein, D. M., Gatsonis, C. A., Gelber, R. D., Lagakos, S. W., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199011083231912 · Cited by 140
Shakespeare, T. P., Gebski, V., Veness, M., & Simes, J. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04522-0 · Cited by 138
Claxton, K. (1999) · Health Economics · Cited by 137
Empirical-Bayes Adjustments for Multiple Comparisons Are Sometimes Useful
Greenland, S., & Robins, J. M. (1991) · Epidemiology · doi:10.1097/00001648-199107000-00002 · Cited by 133
New statistical strategy for monitoring safety and efficacy in single-arm clinical trials.
Thall, P. F., Simon, R. M., & Estey, E. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.296 · Cited by 131
Applying Bayesian ideas in drug development and clinical trials
Spiegelhalter, D. J., Freedman, L. S., & Parmar, M. (1993) · Statistics in Medicine · doi:10.1002/sim.4780121516 · Cited by 131
Self-citationAdaptive Treatment Assignment Methods and Clinical Trials
Simon, R. M. (1977) · Biometrics · doi:10.2307/2529473 · Cited by 128
Givens, G. H., Smith, D. D., & Tweedie, R. L. (1997) · Statistical Science · doi:10.1214/ss/1030037958 · Cited by 127
TUTORIAL IN BIOSTATISTICS: BAYESIAN DATA MONITORING IN CLINICAL TRIALS
Fayers, P. M., Ashby, D., & Parmar, M. (1997) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19970630)16:12<1413::aid-sim578>3.0.co;2-u · Cited by 126
Are distinctive ethical principles required for cluster randomized controlled trials?
Hutton, J. L. (2001) · Statistics in Medicine · doi:10.1002/1097-0258(20010215)20:3<453::aid-sim803>3.0.co;2-l · Cited by 125
Bayesian Graphical Modelling: A Case-Study in Monitoring Health Outcomes
Spiegelhalter, D. J. (1998) · Journal of the Royal Statistical Society Series C (Applied Statistics) · doi:10.1111/1467-9876.00101 · Cited by 125
Self-citationComparison of Bayesian with group sequential methods for monitoring clinical trials
Freedman, L. S., & Spiegelhalter, D. J. (1989) · Controlled Clinical Trials · doi:10.1016/0197-2456(89)90001-9 · Cited by 124
Self-citationHiggins, J. P. T., & Spiegelhalter, D. J. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.96 · Cited by 123
Self-citationThall, P. F., & Sung, H. (1998) · Statistics in Medicine · Cited by 121
Diuretics, β-Blockers, and the Risk for Sudden Cardiac Death in Hypertensive Patients
Hoes, A. W., Grobbee, D. E., Lubsen, J., Veld, A. J. M. I. '., van der Does, E., & Albert Hofman, D. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-7-199510010-00001 · Cited by 120
Combining Historical and Randomized Controls for Assessing Trends in Proportions
Dempster, A. P., Selwyn, M. R., & Weeks, B. J. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477953 · Cited by 119
Bayesian cost‐effectiveness analysis from clinical trial data
O’Hagan, A., Stevens, J., & Montmartin, J. (2001) · Statistics in Medicine · doi:10.1002/sim.861 · Cited by 119
Adaptive Bayesian Designs for Dose-Ranging Drug Trials
Berry, D. A., Müller, P., Grieve, A. P., Smith, M. K., Parke, T., Blazek, R., Mitchard, N., & Krams, M. (2002) · Lecture notes in statistics · doi:10.1007/978-1-4613-0035-9_2 · Cited by 116
Bayesian methods for cluster randomized trials with continuous responses
Spiegelhalter, D. J. (2001) · Statistics in Medicine · Cited by 116
Self-citationHalpern, E. F., Weinstein, M. C., Hunink, M. G. M., & Gazelle, G. S. (2000) · Medical Decision Making · doi:10.1177/0272989x0002000308 · Cited by 115
Interim Analysis in Clinical Trials: The Role of the Likelihood Principle
Berry, D. A. (1987) · The American Statistician · doi:10.1080/00031305.1987.10475458 · Cited by 114
Trials stopped early: too good to be true?
Pocock, S., & White, I. R. (1999) · The Lancet · doi:10.1016/s0140-6736(98)00379-1 · Cited by 113
Clinical significance not statistical significance: a simple Bayesian alternative to p values.
Burton, P. R., Gurrin, L. C., & Campbell, M. J. (1998) · Journal of Epidemiology & Community Health · doi:10.1136/jech.52.5.318 · Cited by 112
The chart trials: Bayesian design and monitoring in practice
Parmar, M., Spiegelhalter, D. J., & Freedman, L. S. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131304 · Cited by 112
Self-citationFreedman, L. S., & Spiegelhalter, D. J. (1983) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2987606 · Cited by 111
Self-citationAN ALTERNATIVE TO THE USE OF TWO-SIDED TESTS IN CLINICAL TRIALS
Dunnett, C. W., & Gent, M. (1996) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19960830)15:16<1713::aid-sim331>3.0.co;2-d · Cited by 110
Approaches for Optimal Sequential Decision Analysis in Clinical Trials
Carlin, B. P., Kadane, J. B., & Gelfand, A. E. (1998) · Biometrics · doi:10.2307/2533849 · Cited by 110
Graphical Elicitation of a Prior Distribution for a Clinical Trial
Chaloner, K. M., Church, T. R., Louis, T. A., & Matts, J. P. (1993) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2348469 · Cited by 106
Spatial variation of natural radiation and childhood leukaemia incidence in Great Britain
Richardson, S. T., Monfort, C., Green, M., Draper, G. J., & Muirhead, C. R. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142116 · Cited by 106
Ades, A. E., & Cliffe, S. (2002) · Medical Decision Making · doi:10.1177/027298902400448920 · Cited by 104
A framework for cost‐effectiveness analysis from clinical trial data
O’Hagan, A., & Stevens, J. (2001) · Health Economics · doi:10.1002/hec.617 · Cited by 104
Why “underpowered” trials are not necessarily unethical
Edwards, S., Lilford, R. J., Braunholtz, D., & Jackson, J. E. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02290-3 · Cited by 104
Comprehensive decision analytical modelling in economic evaluation: a Bayesian approach
Cooper, N. J., Sutton, A. J., Abrams, K. R., Turner, D., & Wailoo, A. (2003) · Health Economics · doi:10.1002/hec.804 · Cited by 103
Self-citationSharp, S. J., & Thompson, S. G. (2000) · Statistics in Medicine · Cited by 102
The what, why and how of bayesian clinical trials monitoring
Freedman, L. S., Spiegelhalter, D. J., & Parmar, M. (1994) · Statistics in Medicine · doi:10.1002/sim.4780131312 · Cited by 101
Self-citationRECENT METHODOLOGICAL CONTRIBUTIONS TO CLINICAL TRIALS
Cornfield, J. (1976) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112313 · Cited by 101
A Bayesian Method for Synthesizing Evidence: The Confidence Profile Method
Eddy, D. M., Hasselblad, V., & Shachter, R. D. (1990) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300008928 · Cited by 98
Adar, R., Critchfield, G. C., & Eddy, D. M. (1989) · Journal of Vascular Surgery · doi:10.1016/0741-5214(89)90286-3 · Cited by 98
Population modelling in drug development
Sheiner, L. B., & Wakefield, J. (1999) · Statistical Methods in Medical Research · doi:10.1177/096228029900800302 · Cited by 98
Modeling in Medical Decision Making: A Bayesian Approach
Parmigiani, G. (2002) · Cited by 97
Bayesian Statistical Methods in Public Health and Medicine
Etzioni, R., & Kadane, J. B. (1995) · Annual Review of Public Health · doi:10.1146/annurev.pu.16.050195.000323 · Cited by 94
The Search for Optimality in Clinical Trials
Armitage, P. (1985) · International Statistical Review · doi:10.2307/1402871 · Cited by 93
The Confidence Profile Method: A Bayesian Method for Assessing Health Technologies
Eddy, D. M. (1989) · Operations Research · doi:10.1287/opre.37.2.210 · Cited by 93
A Bayesian Analysis of Institutional Effects in a Multicenter Cancer Clinical Trial
Gray, R. J. (1994) · Biometrics · doi:10.2307/2533216 · Cited by 92
A Bayesian Analysis of the Two-Period Crossover Design for Clinical Trials
Grieve, A. P. (1985) · Biometrics · doi:10.2307/2530969 · Cited by 88
Estimation issues in clinical trials and overviews
Pocock, S., & Hughes, M. D. (1990) · Statistics in Medicine · doi:10.1002/sim.4780090612 · Cited by 87
Bayesian methods for phase I clinical trials
Gatsonis, C. A., & Greenhouse, J. B. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111011 · Cited by 85
An Introduction to a Bayesian Method for Meta-analysis: The Confidence Profile Method
Eddy, D. M., Hasselblad, V., & Shachter, R. D. (1990) · Medical Decision Making · doi:10.1177/0272989x9001000104 · Cited by 85
Gray, A. P., Clarke, P., Farmer, A., & Holman, R. (2002) · BMJ · doi:10.1136/bmj.325.7369.860 · Cited by 84
Palmer, C. R., & Rosenberger, W. F. (1999) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00056-7 · Cited by 84
The futility index. An approach to the cost-effective termination of randomized clinical trials
Ware, J. H., Muller, J. E., & Braunwald, E. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90407-3 · Cited by 83
Meta-Analysis of Migraine Headache Treatments: Combining Information from Heterogeneous Designs
Dominici, F., Parmigiani, G., Wolpert, R. L., & Hasselblad, V. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10473815 · Cited by 83
Monitoring Clinical Trials Based on Predictive Probability of Significance
Choi, S. C., & Pepple, P. A. (1989) · Biometrics · doi:10.2307/2532056 · Cited by 83
The intellectual health of clinical drug evaluation
Sheiner, L. B. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.97 · Cited by 82
A dynamic programming approach to the efficient design of clinical trials
Claxton, K., & Thompson, K. M. (2001) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00093-5 · Cited by 82
Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events*
Lanctôt, K. L., & Naranjo, C. A. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90026-8 · Cited by 82
Quantifying and documenting prior beliefs in clinical trials
Chaloner, K. M., & Rhame, F. S. (2001) · Statistics in Medicine · doi:10.1002/sim.694 · Cited by 82
Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
O’Hagan, A., Stevens, J., & Montmartin, J. (2000) · PharmacoEconomics · doi:10.2165/00019053-200017040-00004 · Cited by 81
Baseline risk as predictor of treatment benefit: three clinical meta-re-analyses
Arends, L. R., Hoes, A. W., Lubsen, J. C., Grobbee, D. E., & Stijnen, T. (2000) · Statistics in Medicine · doi:10.1002/1097-0258(20001230)19:24<3497::aid-sim830>3.0.co;2-h · Cited by 80
Meta‐analysis: Weighing the evidence
Jones, D. R. H. (1995) · Statistics in Medicine · doi:10.1002/sim.4780140206 · Cited by 79
Droitcour, J. A., Silberman, G., & Chelimsky, E. (1993) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462300004694 · Cited by 77
Pitchforth, J., & Mengersen, K. L. (2012) · Wiley series in probability and statistics · doi:10.1002/9781118394472.ch7 · Cited by 75
The Bayesian Modeling of Covariates for Population Pharmacokinetic Models
Wakefield, J., & Bennett, J. E. (1996) · Journal of the American Statistical Association · doi:10.1080/01621459.1996.10476961 · Cited by 75
Robust bayesian methods for monitoring clinical trials
Greenhouse, J. B., & Waserman, L. (1995) · Statistics in Medicine · doi:10.1002/sim.4780141210 · Cited by 75
Be skeptical about unexpected large apparent treatment effects:
Wheatley, K., & Clayton, D. G. (2003) · Controlled Clinical Trials · doi:10.1016/s0197-2456(02)00273-8 · Cited by 73
Interim analysis in clinical trials
Armitage, P. (1991) · Statistics in Medicine · doi:10.1002/sim.4780100613 · Cited by 72
USING FULL PROBABILITY MODELS TO COMPUTE PROBABILITIES OF ACTUAL INTEREST TO DECISION MAKERS
Harrell, F. E., & Shih, Y. T. (2001) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462301104034 · Cited by 72
Monitoring Accumulating Data in a Clinical Trial
Berry, D. A. (1989) · Biometrics · doi:10.2307/2531771 · Cited by 70
BAYESIAN COST-EFFECTIVENESS ANALYSIS
Fryback, D. G., Chinnis, J. O., & Ulvila, J. W. (2001) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462301104083 · Cited by 69
Cooper, N. J., Sutton, A. J., & Abrams, K. R. (2002) · Statistical Methods in Medical Research · doi:10.1191/0962280202sm306ra · Cited by 69
Self-citationAn introduction to second‐order random variables in human health risk assessments
Burmaster, D. E., & Wilson, A. (1996) · Human and Ecological Risk Assessment An International Journal · doi:10.1080/10807039609383655 · Cited by 69
The Stroke Prevention Policy Model: Linking Evidence and Clinical Decisions
Matchar, D. B., Samsa, G. P., Matthews, J. R., Ancukiewicz, M., Parmigiani, G., Hasselblad, V., Wolf, P. A., D’Agostino, R. B., & Lipscomb, J. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-8_part_2-199710151-00054 · Cited by 68
Clinical Trials and Sample Size Considerations: Another Perspective
Lee, S. J., & Zelen, M. (2000) · Statistical Science · doi:10.1214/ss/1009212752 · Cited by 67
On choosing the number of interim analyses in clinical trials
McPherson, K. (1982) · Statistics in Medicine · doi:10.1002/sim.4780010105 · Cited by 67
Stopping guidelines vs stopping rules: a practitioner's point of view
DeMets, D. L. (1984) · Communication in Statistics- Theory and Methods · doi:10.1080/03610928408828833 · Cited by 66
Bayesian statistics in medical research: an intuitive alternative to conventional data analysis
Gurrin, L. C., Kurinczuk, J. J., & Burton, P. R. (2000) · Journal of Evaluation in Clinical Practice · doi:10.1046/j.1365-2753.2000.00216.x · Cited by 65
Li, Z., & Begg, C. (1994) · Journal of the American Statistical Association · doi:10.1080/01621459.1994.10476892 · Cited by 65
An introduction to the Bayesian analysis of clinical trials
Lewis, R., & Wears, R. L. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80119-2 · Cited by 64
A Brief History of Statistics in Three and One-Half Chapters: A Review Essay
Fienberg, S. E. (1992) · Statistical Science · doi:10.1214/ss/1177011360 · Cited by 63
Kendall's Advanced Theory of Statistics: Vol. 2B, Bayesian Inference.
Dickey, J., & O’Hagan, A. (1996) · Journal of the American Statistical Association · doi:10.2307/2291686 · Cited by 63
High energy neutron treatment for pelvic cancers: study stopped because of increased mortality.
Errington, R. D., Ashby, D., Gore, S., Abrams, K. R., Myint, S., Bonnett, D. E., Blake, S. W., & Saxton, T. (1991) · BMJ · doi:10.1136/bmj.302.6784.1045 · Cited by 62
Self-citation
Cited by
Hutton, B., Salanti, G., Caldwell, D. M., Chaimani, A., Schmid, C. H., Cameron, C., Ioannidis, J. P. A., Straus, S., Thorlund, K., Jansen, J. P., et al. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2385 · Cited by 8,269
The Handbook of Research Synthesis and Meta-Analysis
(2019) · doi:10.7758/9781610448864 · Cited by 4,553
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050
Initial Invasive or Conservative Strategy for Stable Coronary Disease
Maron, D. J., Hochman, J. S., Reynolds, H. R., Bangalore, S., O’Brien, S. M., Boden, W. E., Chaitman, B. R., Senior, R., López-Sendón, J., Alexander, K. P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915922 · Cited by 2,449
Analysing data and undertaking meta‐analyses
Deeks, J. J., Higgins, J. P., Altman, D. G., & on behalf of the Cochrane Statistical Methods Group (2019) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9781119536604.ch10 · Cited by 2,672
Metadata
- Authors
- Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P.
- Venue
- Wiley eBooks
- Publisher
- Wiley
- Published
- 2003-12-09
- Issue
- 1
- OpenAlex
- W1479881385
- Cited by
- 1,673
- References
- 287
- FWCI
- 8.71
- Type
- book
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.